Osuorji Chinenye, Bilal Jawad, Osuorji Ikenna
Internal Medicine, Burrell College of Osteopathic Medicine, Las Cruces, New Mexico, USA
Rheumatology, University of Arizona, Tucson, Arizona, USA.
BMJ Case Rep. 2022 Mar 25;15(3):e246104. doi: 10.1136/bcr-2021-246104.
Antiphospholipid syndrome may cause recurrent thromboembolic events of the microvasculature, arteries and veins. It is also characterised by a range of neurological and psychiatric dysfunctions, as well as complications during pregnancy. Patients with triple-positive antiphospholipid syndrome have persistently elevated levels of lupus anticoagulant (LA), anti-beta-2-glycoprotein I (B2GPI) and anticardiolipin antibodies (aCL). These patients also have a higher risk of initial or recurrent thrombosis.We report the case of a 36-year-old man who was presented with progressive memory loss and recurrent stroke. He had persistently elevated antiphospholipid antibody titres (LA, aCL-immunoglobulin G and B2GPI antibodies). These features persisted while the patient was receiving low-dose aspirin (LDA), 81mg daily. Vitamin K antagonist (VKA); warfarin, with the international normalised ratio (INR) maintained at 2-3 was then added to his treatment regimen. The VKA dose was maintained at - a higher therapeutic INR while LDA administration was continued to achieve resolution of the patient's symptoms.
抗磷脂综合征可能导致微血管、动脉和静脉的反复血栓栓塞事件。它还具有一系列神经和精神功能障碍以及妊娠并发症的特征。抗磷脂综合征三联阳性患者的狼疮抗凝物(LA)、抗β2糖蛋白I(B2GPI)和抗心磷脂抗体(aCL)水平持续升高。这些患者发生初始或复发性血栓形成的风险也更高。我们报告了一例36岁男性患者,该患者出现进行性记忆力减退和复发性中风。他的抗磷脂抗体滴度(LA、aCL-免疫球蛋白G和B2GPI抗体)持续升高。在患者每天服用81mg低剂量阿司匹林(LDA)期间,这些特征持续存在。随后在其治疗方案中添加了维生素K拮抗剂(VKA)华法林,国际标准化比值(INR)维持在2至3。在继续服用LDA的同时,将VKA剂量维持在较高的治疗性INR水平,以缓解患者的症状。